|  | T2D Cases | NGT |  |
---|---|---|---|---|
 | Gender | 532 (299M/233F)* | 386 (184M/202F) | pvalue** |
Age (yrs) | M* | 53. 2 ± 11.1 | 51.7 ± 15.6 | 0.006 |
 | F | 55.2 ± 11.0 | 50.8 ± 13.0 | 0.001 |
Age at | Â | Â | Â | Â |
diagnosis (yrs) | M | 47.5 ± 10.9 | -- | -- |
 | F | 48.2 ± 10.5 | -- | -- |
Duration of | Â | Â | Â | Â |
Diabetes (yrs) | M | 8.6 ± 7.4 | -- | -- |
 | F | 7.3 ± 6.0 | -- | -- |
BMI | M | 26.6 ± 4.3 | 26.6 ± 4.4 | 0.912 |
 | F | 29.0 ± 5.5 | 27.5 ± 4.9 | <0.001 |
WHR†| M | 0.99 ± 0.06 | 0.97 ± 0.07 | 0.002 |
 | F | 0.93 ± 0.07 | 0.91 ± 0.07 | <0.001 |
Fasting Glucose | Â | Â | Â | Â |
(mmol/l) | M | 10.1 ± 3.7 | 5.4 ± 0.6 | <0.0001 |
 | F | 10.0 ± 3.5 | 5.4 ± 0.5 | <0.0001 |
Fasting | Â | Â | Â | Â |
Insulin(IU/ml) | M | 9.1 ± 7.9 | 11.0 ± 9.2 | 0.057 |
 | F | 8.8 ± 7.4 | 11.5 ± 9.5 | 0.002 |
HbA1c (%) | M | 8.6 ± 2.4 | 5.6 ± 0.7 | <0.0001 |
 | F | 8.6 ± 2.5 | 5.6 ± 0.7 | <0.0001 |